Publication | Closed Access
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.
106
Citations
15
References
1996
Year
Intraperitoneal radioimmunotherapy with 177Lu-CC49 is well tolerated and appears to have antitumor activity against chemotherapy-resistant ovarian cancer in the peritoneal cavity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1